NUSConsumer Defensive · Household & Personal ProductsTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 59 of 100 as at 12 Nov 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Nu Skin Enterprises, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (94): The share count has been shrinking and the company is not leaning on new borrowing.
Momentum (14): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on NUS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 20 Dec 2024 | DA Davidson | Maintains | Neutral | $11 → $7.00 |
| 22 Oct 2024 | Citigroup | Maintains | Neutral | — |
| 12 Aug 2024 | DA Davidson | Maintains | Neutral | — |
| 9 Aug 2024 | Citigroup | Maintains | Neutral | — |
| 9 May 2024 | DA Davidson | Maintains | Neutral | — |
| 5 Jan 2024 | DA Davidson | Maintains | Neutral | — |
| 16 Oct 2023 | Stifel | Maintains | Hold | — |
| 29 Sept 2023 | Citigroup | Maintains | Neutral | — |
| 3 Aug 2023 | DA Davidson | Reiterates | Neutral | — |
| 2 Aug 2023 | Stifel | Maintains | Hold | — |
| 19 May 2023 | DA Davidson | Reiterates | Neutral | — |
| 1 Mar 2023 | Citigroup | Maintains | Neutral | — |
| 16 Feb 2023 | DA Davidson | Maintains | Neutral | — |
| 31 Jan 2023 | Jefferies | Downgrade | Hold | — |
| 23 Nov 2022 | DA Davidson | Maintains | Neutral | — |
| 5 Oct 2022 | Citigroup | Maintains | Neutral | — |
| 23 Aug 2022 | DA Davidson | Maintains | Neutral | — |
| 8 Aug 2022 | Citigroup | Maintains | Neutral | — |
| 5 May 2022 | DA Davidson | Maintains | Neutral | — |
| 17 Feb 2022 | DA Davidson | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
NUS appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 12 Nov 2026, Nu Skin Enterprises, Inc. returned −56.6% against +12.0% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 66% of US stocks
Cheaper than 93% of US stocks
Cheaper than 85% of US stocks
Cheaper than 56% of US stocks
Higher than 14% of US stocks
Higher than 22% of US stocks
Higher than 81% of US stocks
Higher than 54% of US stocks
Higher than 16% of US stocks
Higher than 26% of US stocks
Higher than 63% of US stocks
Higher than 94% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Nu Skin Enterprises, Inc. has a market value of $189.4M and an enterprise value of $300.0M.
Revenue in the twelve months to 30 June 2026: $1.4B. The latest quarter shrank 14.6% year on year.
Net income over the same four quarters: −$216.4M, a −15.7% net margin.
Diluted earnings per share, trailing twelve months: −$4.47.
Free cash flow in the twelve months to 30 June 2026: $10.8M.
Nu Skin Enterprises, Inc. spent $20.0M on share buybacks and $11.7M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 4.8×; forward P/E: 3.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 6.19%, paying out 22% of earnings.
Nu Skin Enterprises, Inc. employs 2,800 people — $491K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Nu Skin Enterprises, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Nu Skin Enterprises reported third-quarter 2026 revenue of $311 million and adjusted earnings of $0.10 per share, both within its guidance ranges. Growth in its Rhyz manufacturing business helped offset pressure in core operations.
Why it matters — The results highlight how Rhyz growth contributed to performance amid pressure in Nu Skin’s core operations.
The excerpt identifies Nu Skin Enterprises’ Q3 2026 earnings call, held November 5, 2026, and lists company and conference-call participants. It provides no earnings results or substantive discussion.
Why it matters — NUS watchers can note that the excerpt is only call-opening information and contains no financial or operational details.
Nu Skin Enterprises reported quarterly earnings of $0.10 per share, below the Zacks Consensus Estimate of $0.21. Earnings were $0.34 per share in the year-ago quarter.
Why it matters — The earnings miss and year-over-year decline are relevant to investors tracking NUS’s quarterly results.
Nu Skin Enterprises issued a corrected version of its third-quarter earnings release. The correction updates figures for the nine months ended September 2026 in the reconciliation table for the valuation allowance on deferred tax assets and adjusted net income.
Why it matters — NUS watchers should refer to the corrected release for the revised figures in those earnings reconciliation items.
Nu Skin reported third-quarter revenue of $311.0 million, down 14.6% year over year and within its guidance range. EPS was $(0.02), or $0.10 excluding certain charges, compared with $0.34 a year earlier; customers, paid affiliates and sales leaders also declined year over year.
Why it matters — The report gives NUS watchers an update on revenue, earnings and changes in key customer and affiliate metrics.
As at 12 Nov 2026, Nu Skin Enterprises, Inc. ranks 59 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (94 of 100).
No analyst covering Nu Skin Enterprises, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NUS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $12 to $12 over the next 12 months.
Nu Skin Enterprises, Inc. returned -56.6% over the 12 months to 12 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Nu Skin Enterprises Inc. Class A is a consumer health and personal care company that develops and distributes beauty and wellness products worldwide.
The most recent item we track (MarketBeat, 8 Nov 2026): "What Nu Skin Enterprises (NUS) Said on Its Q3 Earnings Call". Nu Skin Enterprises reported third-quarter 2026 revenue of $311 million and adjusted earnings of $0.10 per share, both within its guidance ranges. Growth in its Rhyz manufacturing business helped offset pressure in core operations.
Nu Skin Enterprises Inc. Class A is a consumer health and personal care company that develops and distributes beauty and wellness products worldwide. The company offers a broad portfolio that includes skin care systems and devices, cosmetics, nutritional supplements, weight-management products, and other personal care solutions under brands such as Nu Skin, Pharmanex, and ageLOC. Its business is centered on direct selling and person-to-person marketing, supported by digital tools and a network of independent distributors. Nu Skin serves customers across multiple international markets, with a focus on beauty, anti-aging, and wellness categories. The company plays a role in the global consumer products market by combining product development, brand marketing, and distributed sales channels to reach households and individual consumers.
CEO Mr. Ryan S. Napierski · 2,800 employees · United States · https://www.nuskin.com
